UCB/€UCB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About UCB
UCB SA, founded in 1928, is a global biopharmaceutical company headquartered in Brussels, Belgium. The company specializes in the research, development, and commercialization of innovative therapies primarily for the treatment of neurological and immunological disorders. Operating in the healthcare sector, UCB is dedicated to advancing science and addressing unmet medical needs for patients worldwide.
Ticker
€UCB
Sector
Primary listing
BSE
Employees
9,765
Headquarters
Website
UCB Metrics
BasicAdvanced
€44bn
28.19
€8.20
0.23
-
Price and volume
Market cap
€44bn
Beta
0.23
52-week high
€288.90
52-week low
€146.05
Average daily volume
510
Financial strength
Current ratio
1.376
Quick ratio
0.942
Long term debt to equity
20.088
Total debt to equity
20.659
Dividend payout ratio (TTM)
16.94%
Interest coverage (TTM)
15.52%
Profitability
EBITDA (TTM)
2,614
Gross margin (TTM)
74.29%
Net profit margin (TTM)
20.13%
Operating margin (TTM)
25.95%
Effective tax rate (TTM)
14.49%
Revenue per employee (TTM)
€790,000
Management effectiveness
Return on assets (TTM)
7.00%
Return on equity (TTM)
14.91%
Valuation
Price to earnings (TTM)
28.189
Price to revenue (TTM)
5.677
Price to book
4.05
Price to tangible book (TTM)
18.88
Price to free cash flow (TTM)
23.858
Free cash flow yield (TTM)
4.19%
Free cash flow per share (TTM)
9.689
Growth
Revenue change (TTM)
25.83%
Earnings per share change (TTM)
46.53%
3-year revenue growth (CAGR)
12.43%
10-year revenue growth (CAGR)
7.16%
3-year earnings per share growth (CAGR)
55.40%
10-year earnings per share growth (CAGR)
9.72%
3-year dividend per share growth (CAGR)
2.92%
10-year dividend per share growth (CAGR)
2.80%
What the Analysts think about UCB
Analyst ratings (Buy, Hold, Sell) for UCB stock.
UCB Financial Performance
Revenues and expenses
UCB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for UCB stock?
UCB (UCB) has a market cap of €44B as of May 06, 2026.
What is the P/E ratio for UCB stock?
The price to earnings (P/E) ratio for UCB (UCB) stock is 28.19 as of May 06, 2026.
Does UCB stock pay dividends?
No, UCB (UCB) stock does not pay dividends to its shareholders as of May 06, 2026.
When is the next UCB dividend payment date?
UCB (UCB) stock does not pay dividends to its shareholders.
What is the beta indicator for UCB?
UCB (UCB) has a beta rating of 0.23. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.